New UK guideline for clopidogrel recommends pharmacogenetic testing for all patients before prescription

The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use of the antiplatelet medication clopidogrel,…

Continue Reading

News Source: medicalxpress.com